Keyphrases
Circulating Tumor Cells
100%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
100%
Epithelial-mesenchymal Transition
67%
Scalp Reconstruction
50%
Germline Genetic Variation
50%
Mass Cytometry
50%
Proteomics Characterization
50%
Dermal Regeneration Template
50%
Induced Toxicity
50%
Deep Phenotyping
50%
Integra
50%
Immune Checkpoint Inhibitors
50%
Immune-related Adverse Events
50%
Skin Graft
30%
Scalp Defect
20%
IrAE
14%
Autoimmune Disease
14%
Parsortix
12%
Transition Profile
11%
Flap Coverage
10%
Local Flap
10%
Full-thickness Scalp Defects
10%
Human Skin Cancer
10%
Independent Risk Factors
10%
Acellular Dermal
10%
Success Rate
10%
Further Surgery
10%
Retrospective Analysis
10%
Surgical Reconstruction
10%
Defect Depth
10%
Comorbid Patients
10%
Minor Complications
10%
Anticoagulation Medication
10%
Donor Site Morbidity
10%
Excision
10%
Partial Thickness
10%
Postoperative Infection
10%
Head-and-neck Radiotherapy
10%
Time to Healing
10%
Complication Rate
10%
Large Defects
10%
Microfluidic Enrichment
9%
Tumor
9%
Gene Expression
9%
Flow Cytometry
9%
Flow Cytometric Analysis
8%
Nave
8%
Germline Genetics
7%
Cycle Development
7%
Patient Identification
7%
Immune Function
7%
Anticancer Immune Response
7%
Polygenic Risk Score
7%
Immune Checkpoint Inhibitor Therapy
7%
Genetic Variants
7%
T Cell Activation
7%
Event Occurrence
7%
Immune Response
7%
Cancer Types
7%
Host Genetics
7%
Cancer-immunity Cycle
7%
Host Immune Response
7%
Disease-related
7%
High Risk
7%
Patient Care
7%
Immunomodulatory Factors
7%
Autoimmune
7%
Off-target Effects
7%
Genetic Determinants
7%
Host Genome
7%
Genome-wide Association Study
7%
Immune Checkpoint
7%
Single-cell Resolution
7%
Medicine and Dentistry
Head and Neck Squamous Cell Carcinoma
100%
Circulating Tumor Cell
100%
Mesenchymal-Epithelial Transition
65%
Scalp Reconstruction
50%
Mass Cytometry
50%
Scalp
50%
DNA Template
50%
Proteomics
50%
Regeneration
50%
Skin Graft
33%
Neoplasm
16%
Skin Flap
16%
Postoperative Infection
16%
Reconstructive Surgery
16%
Donor Site
16%
Skin Cancer
16%
Anticoagulation
16%
Skin Transplantation
16%
Neck Radiotherapy
16%
Head Radiotherapy
16%
Flow Cytometry
13%
Gene Expression
12%
Biological Marker
7%
Biochemistry, Genetics and Molecular Biology
Mesenchymal-Epithelial Transition
91%
Immune Checkpoints
75%
Genetic Divergence
50%
Mass Cytometry
50%
Germ Cell
50%
Genetic Variation
50%
Germline
50%
Proteomics
50%
Immune Response
33%
Gene Expression
19%
Flow Cytometry
16%
Cell Function
16%
Polygenic Score
16%
Genome-Wide Association Study
16%
Genetic Determinism
16%
Genetics
16%
Tumor Immunity
16%
Intravenous Immunoglobulin
16%
T Cell
16%
Anticancer
16%
Cell Lineage
8%
Immunocompetent Cell
8%
Signaling Protein
8%
Tumor Marker
8%
Cell Count
8%
Tumor Gene
8%
Signal Transduction
8%
Progression Free Survival
5%
Overall Survival
5%